Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Quantum-Si Says Co. Is Terminating ~12% Of Workforce, Effective In Q1’23

-SEC Filing

byMichael Horton

January 30, 2023

1 minute read

-SEC Filing

Stoke Therapeutics Q2 EPS $(0.60) Down From $(0.39) YoY

By Benzinga Newsdesk

August 10, 7:20 AM

Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.60) per share. This is a 53.85 percent decrease over losses of $(0.39) per share from the same period last year.

STOK

Dillard’s Reports $15/Share Special Dividend

By Benzinga Newsdesk

November 18, 6:30 PM

Also Declares Cash Dividend of $0.20 per Share LITTLE ROCK, Ark.--(BUSINESS WIRE)-- Dillard’s, Inc. (NYSE:DDS) (the “Company” or “Dillard’s”) announced that the Board of Directors

DDS

Morgan Stanley Maintains Overweight on Lululemon Athletica, Raises Price Target to $315

By Benzinga Newsdesk

June 16, 7:45 AM

Morgan Stanley maintains Lululemon Athletica (NASDAQ:LULU) with a Overweight and raises the price target from $303 to $315.

LULU

Events
News

Arbutus Announces Late-Breaker Abstract Accepted For Presentation At AASLD – The Liver Meeting 2021

By Benzinga Newsdesk

November 1, 4:19 PM

Arbutus Biopharma Corporation (NASDAQ:ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a broad portfolio of wholly-owned assets with different mechanisms

ABUS

Quantum-Si Says Co. Is Terminating ~12% Of Workforce, Effective In Q1’23

Related Posts

Stoke Therapeutics Q2 EPS $(0.60) Down From $(0.39) YoY

Dillard’s Reports $15/Share Special Dividend

Morgan Stanley Maintains Overweight on Lululemon Athletica, Raises Price Target to $315

Arbutus Announces Late-Breaker Abstract Accepted For Presentation At AASLD – The Liver Meeting 2021